Literature DB >> 22491855

RNA aptamers: a review of recent trends and applications.

Kyung-Nam Kang1, Yoon-Sik Lee.   

Abstract

RNA aptamers, small oligonucleotides derived by an in-vitro selection process called SELEX (Systematic Evolution of Ligands by EXperimental enrichment), are important candidates for therapeutic and diagnostic applications. RNA aptamers have high affinity and specificity for their target molecules. In this review, we describe methods for generating RNA aptamers (the SELEX technique and modified SELEX processes) and therapeutic applications for diseases such as neovascular age-related macular degeneration (AMD), inflammatory diseases, and obesity. We also analyze the social networks among researchers and organizations (universities, research institutes, firms, etc.) that are active in the pursuit of aptamer-based therapeutic approaches. This study provides relevant information on recent research trends in RNA aptamers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22491855     DOI: 10.1007/10_2012_136

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  17 in total

Review 1.  Targeted Nanotherapies for the Treatment of Surgical Diseases.

Authors:  Courtney E Morgan; Molly A Wasserman; Melina R Kibbe
Journal:  Ann Surg       Date:  2016-05       Impact factor: 12.969

Review 2.  Protein-Catalyzed Capture Agents.

Authors:  Heather D Agnew; Matthew B Coppock; Matthew N Idso; Bert T Lai; JingXin Liang; Amy M McCarthy-Torrens; Carmen M Warren; James R Heath
Journal:  Chem Rev       Date:  2019-03-06       Impact factor: 60.622

3.  Facile and Cost-Effective Detection of Saxitoxin Exploiting Aptamer Structural Switching.

Authors:  Karol Alfaro; Paulina Bustos; Ciara O Sullivan; Pablo Conejeros
Journal:  Food Technol Biotechnol       Date:  2015-09       Impact factor: 3.918

Review 4.  When Cancer Fights Back: Multiple Myeloma, Proteasome Inhibition, and the Heat-Shock Response.

Authors:  Shardule P Shah; Sagar Lonial; Lawrence H Boise
Journal:  Mol Cancer Res       Date:  2015-05-26       Impact factor: 5.852

Review 5.  Synthesizing biomolecule-based Boolean logic gates.

Authors:  Takafumi Miyamoto; Shiva Razavi; Robert DeRose; Takanari Inoue
Journal:  ACS Synth Biol       Date:  2013-02-15       Impact factor: 5.110

6.  Development of RNA aptamers targeting Ebola virus VP35.

Authors:  Jennifer M Binning; Tianjiao Wang; Priya Luthra; Reed S Shabman; Dominika M Borek; Gai Liu; Wei Xu; Daisy W Leung; Christopher F Basler; Gaya K Amarasinghe
Journal:  Biochemistry       Date:  2013-11-14       Impact factor: 3.162

7.  Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers.

Authors:  Nianxi Zhao; Sung-nan Pei; Parag Parekh; Eric Salazar; Youli Zu
Journal:  Int J Biochem Cell Biol       Date:  2014-03-22       Impact factor: 5.085

Review 8.  Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity.

Authors:  Daniel W Binzel; Xin Li; Nicolas Burns; Eshan Khan; Wen-Jui Lee; Li-Ching Chen; Satheesh Ellipilli; Wayne Miles; Yuan Soon Ho; Peixuan Guo
Journal:  Chem Rev       Date:  2021-05-26       Impact factor: 72.087

9.  Current progress of RNA aptamer-based therapeutics.

Authors:  Jiehua Zhou; Maggie L Bobbin; John C Burnett; John J Rossi
Journal:  Front Genet       Date:  2012-11-02       Impact factor: 4.599

Review 10.  RNA modularity for synthetic biology.

Authors:  Wade Grabow; Luc Jaeger
Journal:  F1000Prime Rep       Date:  2013-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.